SPONSOR
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Total Trials
10
Recruiting
10
Phases
Phase 4, Phase 2
Conditions studied: AtherosclerosisObesityWeight LossMetabolic SurgeryType 2 Diabetes Mellitus (T2DM)Mild Cognitive Impairment (MCI)Subjective Cognitive Decline (SCD)Hematoma BrainLarge Basal Ganglia HemorrhageObesity & Overweight
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School is a clinical research sponsor with 10 registered studies on ClinicalTrials.gov, of which 10 are actively recruiting participants. Research covers conditions including Atherosclerosis, Obesity, Weight Loss, Metabolic Surgery.
The trial portfolio spans Phase 4, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
How many clinical trials has The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School sponsored?
ClinicalMetric currently tracks 10 clinical trials sponsored by The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, of which 10 are actively recruiting participants. These trials cover conditions including Atherosclerosis, Obesity, Weight Loss. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School research focus on?
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School clinical trials span Atherosclerosis, Obesity, Weight Loss, Metabolic Surgery, Type 2 Diabetes Mellitus (T2DM), and additional conditions. The research pipeline includes Phase 4, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School clinical trial?
To participate in a The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School trials with current recruitment status updated daily.
Clinical Trials by The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
NCT06551805
Recruiting
Clinical Research Protocol of Ferumoxytol for Magnetic Resonance Enhancement Imaging in Patients With Atherosclerosis.
Atherosclerosis
NCT07163650 Phase 4
Recruiting
Evaluating Anti-Obesity Medications 6 Months After Metabolic Surgery
Obesity
NCT07650318
Recruiting
The Cognitive Protective Effect of VR-based Cognitive Training in Type 2 Diabetes Patients With Mild Cognitive Impairment
Type 2 Diabetes Mellitus (T2DM)
NCT06758154
Recruiting
Efficacy and Olfactory Network of Electro-acupuncture for Subjective Cognitive Decline
Subjective Cognitive Decline (SCD)
NCT06484374
Recruiting
A Multicenter, RAndomlzed, coNtrolled, umBrella Trial fOr Minimally Invasive Neurosurgery With Al-assisted Robotic guidanCe for Hemorrhagic Stroke: Large Basal Ganglia Hemorrhage
Hematoma Brain
NCT07630597
Recruiting
Transcutaneous Auricular Vagus Nerve Stimulation for Poor Weight-Loss Response to Lifestyle Intervention
Obesity & Overweight
NCT07382284
Recruiting
Long-Term Survival After LVAD Implantation in End-Stage Heart Failure
End-stage Heart Failure
NCT07514637 Phase 2
Recruiting
Safety and Efficacy of Anricfen for Postoperative Analgesia and Rehabilitation Promotion After Pancreaticoduodenectomy.Intervention Measures: For Normal Adults, Administer Ariceptin Injection Intravenously Post-operation at a Dose of 1 μg/Kgevery 8 Hours for Three Consecutive Days After Surgery.
Patients Who Undergo Pancreaticoduodenectomy
NCT07603128
Recruiting
Multicenter Validation of a Risk Prediction Model for MDRGNB Infection
Infection
NCT07732777
Recruiting
AI-Assisted Remote Insulin Pump Optimization in T1DM
Type 1 Diabetes Mellitus
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology